INS and type 2 diabetes mellitus: Knowing the pathogenic mechanisms of T2DM, targeted and rational therapeutic approaches can be identified, such as the use of sulfonylurea drugs when the mechanism of β-cell dysfunction predominates, acting by stimulating insulin secretion [36].